obesity glp-1 news today GLP-1 Obesity Drug News Today: Medicare Update

GLP-1RA and thyroid cancer: New study suggests detection bias, not causation

23.68

★★★★☆4.8 (126)

Is it safe to start a GLP‑1 receptor agonist (e.g., exenatide, liraglutide) in a patient with thyroid nodules?

21.88

★★★★★4.9 (98)

Thyroid nodules holding you back from GLP-1 medications? , ✅ Thyroid nodules are super common , ✅ Most are benign (not cancer) , ✅ GLP-1s are usually safe AFTER proper evaluation , ❌ Exception:

23.56

★★★★★5.0 (157)

Does Using GLP-1 Drugs, Like Zepbound or Wegovy, Increase Your Risk of Thyroid Cancer?

23.97

★★★★★4.7 (84)

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

21.56

★★★★★4.9 (203)

GLP-1 Receptor Agonists and Thyroid Cancer Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of medullary thyroid

24.33

★★★★★5.0 (176)

Is it safe for a mother with multiple thyroid nodules to use GLP-1 (Glucagon-like peptide-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), for weight loss or metabolic control?

25.12

★★★★★4.8 (132)